Forward P/S Multiple: Dynatronics Corp (DYNT)
The forward P/S of Dynatronics Corporation (DYNT) reflects market confidence, with the metric holding at 0.00. This optimism is driven by the availability of comprehensive rehabilitation solutions and a streamlined distribution network. Partnerships with hospitals and sports medicine centers continue to support growth. Planned plant capacity utilization and the implementation of automated quality control systems ensure fundamental stability.
Summary analytical data breakdowns for dynatronics.com (DYNT)
- market price and analyst price targets:
- company stock exchange capitalization indicators:
- issuer book value statistics:
- debt and liquidity data:
Total Debt to Capital Dynatronics Corporation|DYNT - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Dynatronics|DYNT - Company Aggregate Debts|Debt to Book Capitalization Ratio Dynatronics Corporation|DYNT - Company Long-Term Debt|Company Current Liabilities Dynatronics|Quick Ratio dynatronics.com
- financial results and valuation multiples details:
DYNT - Company Net Income|Expected Profit Dynatronics Corporation|DYNT - Market Cap to Net Income Ratio|Projected Price to Earnings Dynatronics|DYNT - PEG Multiple|EV/EBITDA Multiple Dynatronics Corporation|DYNT - Operating income before deduction of amortization|Earnings per share for the last twelve months Dynatronics|DYNT - Earnings per one share for the last 12 months|Year-over-year earnings per share growth for the last twelve months dynatronics.com|DYNT - Net earnings per share growth this year|Earnings growth forecast for next year Dynatronics Corporation
- sales and revenue indicators:
Fundamental company analysis:DYNT (Dynatronics Corp.)
Investors assess asset quality through market capitalization dynamics relative to projected revenue, where an upward trend in the expected P/S ratio confirms growing confidence in future earnings. For Dynatronics Corporation (DYNT), this metric reflects business resilience within the rehabilitation equipment niche, where moderate operating leverage and cost control render the valuation less volatile amid stable scalability.
Who Dynatronics Corporation competes with
Price-to-Projected Revenue Ratio Boston Scientific Corporation BSX|EW - Forward Price-to-Revenue Multiple|ResMed Corp - Forward P/S Multiple|Market Cap to Future Revenue Ratio Insulet Inc.|ZBH: Forward P/S Multiple|Market Cap to Projected Revenue COO|ALGN (Align Technology) - Forward P/S Multiple|Globus Medical Inc (GMED) - Market Cap to Expected Sales Ratio|Forward P/S Multiple TMDX|Forward Price-to-Revenue Multiple Alphatec Corp ATEC|Forward P/S Multiple AORT (Artivion, Inc.)|Forward P/S Multiple enovis.com ENOV|IART - Price-to-Projected Revenue Ratio|ESTA: Price-to-Projected Revenue Ratio|BBNX (Beta Bionics Corp) - Forward Price-to-Revenue Multiple|IRADIMED Inc. - Forward Price to Sales|EMBC (Embecta Corp.) - Forward P/S Multiple|Market Cap to Future Revenue Ratio tandemdiabetes.com TNDM|Price-to-Projected Revenue Ratio Axogen (AXGN)|SI-BONE Inc (SIBN) - Projected Price to Revenue|Orthofix International - Forward Price-to-Revenue Multiple|Forward P/S Multiple Bioventus Global BVS|OrthoPediatrics Inc. - Forward P/S Multiple|Market Cap to Expected Sales Ratio treace.com TMCI|Strata Critical Medical (SRTA) - Price-to-Projected Revenue Ratio|Future Price to Revenue CARL (Carlsmed, Inc.)|Price-to-Projected Revenue Ratio RxSight Corp|Forward Price-to-Revenue Multiple ClearPoint (CLPT)|Forward P/S Multiple STXS|STIM - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Sight Sciences SGHT|OBIO: Market Cap to Projected Revenue|ANIK: Forward Price-to-Revenue Multiple|InspireMD Inc. - Price to Expected Revenue Ratio|ZJYL: Forward P/S Multiple|Market Cap to Projected Revenue VANI|Forward Price-to-Revenue Multiple XTNT|Market Cap to Future Revenue Ratio NeuroOne NMTC|Price-to-Projected Revenue Ratio Modular Medical (MODD)|Myomo Inc - Market Cap to Projected Revenue|Forward P/S Multiple COCH (Envoy Medical, Inc.)|Forward P/S Multiple vivoslife.com VVOS|NVNO: Forward Price-to-Revenue Multiple|Sintx Technologies - Price to Expected Revenue Ratio|Tenon Medical, Inc (TNON) - Price-to-Projected Revenue Ratio|Lifeward Ltd. - Forward Price to Sales|Price-to-Projected Revenue Ratio Autonomix Medical Inc.|Market Cap to Future Revenue Ratio invobioscience.com IVF|Price-to-Projected Revenue Ratio Bone Biologics Corp (BBLG)|Axonics Inc. - Market Cap to Projected Revenue|Forward P/S Multiple BIOL (Biolase, Inc.)|Market Cap to Expected Sales Ratio Paragon 28 Inc. (FNA)|INVO Bio - Forward P/S Multiple
